{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:43:39Z","timestamp":1792417419106,"version":"4.4.0"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Critical values in laboratory testing and alert values for therapeutic drug monitoring (TDM) are essential for clinical safety and psychotropic drug optimization, yet their distribution, associated factors, and clinical significance in psychiatric specialty hospitals remain insufficiently characterized. Therefore, we aimed to determine these parameters to provide a theoretical basis for optimizing critical value management and psychotropic drug use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted on critical value reports from the clinical laboratory and TDM alert value data of inpatients and outpatients at the Affiliated Mental Health Center of Kunming Medical University from January 2016 to December 2025. The incidence of critical and TDM alert values, sex and age differences, project composition ratios, and distributions by ward and disease diagnoses were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 3700 reports of critical and TDM alert values were included with 27.27% older than 65 years (63.49% female and 36.51% male). Among the categories of hematological routine, biochemical, coagulation critical values, and hematological drug concentration monitoring warning values, hematological drug concentration monitoring warning values accounted for the highest proportion. (49.73%) and among individual test items, the top\u2011five items were: white blood cell count (15.89%), serum potassium (8.87%), myoglobin (7.06%), glucose (6.27%), and TDM venlafaxine and its metabolites (5.81%). The critical and TDM alert values came from the geriatric psychiatry (1220 cases; 32.97%), outpatient (803 cases; 21.70%), and sleep medicine (8.08%) departments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In this psychiatric specialty hospital, Among the categories of hematological routine, biochemical, coagulation critical values, and hematological drug concentration monitoring warning values, hematological drug concentration monitoring warning values accounted for the highest proportion. The predominant individual issues included leukopenia, hypokalemia, hyperglycemia, and elevated venlafaxine metabolite levels, which may be associated with the adverse effects of psychotropic medications, patient adherence, and comorbid physical illnesses. Individualized critical and TDM alert value thresholds should be determined based on specific characteristics to provide healthcare professionals with reference criteria for assessing disease severity to improve the quality of critical value management and medication use and reducing the incidence of adverse outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001529","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:04:54Z","timestamp":1792415094000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["6.42 Million Tests Reviewed: Analysis of Critical Value Evolution Characteristics and Therapeutic Drug Monitoring Warning Value in a Psychiatric Hospital Over 10 Years"],"prefix":"10.1097","author":[{"given":"Shu","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Research and Education, The Affiliated Mental Health Center of Kunming Medical University, Kunming, Yunnan Province, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqun","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The First People's Hospital of Zhaotong City, Zhaotong, Yunnan Province, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Research and Education, The Affiliated Mental Health Center of Kunming Medical University, Kunming, Yunnan Province, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Affiliated Mental Health Center of Kunming Medical University, Kunming, Yunnan Province, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"He","sequence":"additional","affiliation":[{"name":"Department of Information, The Affiliated Mental Health Center of Kunming Medical University, Kunming, Yunnan Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhao","family":"Bao","sequence":"additional","affiliation":[{"name":"Department of Research and Education, The Affiliated Mental Health Center of Kunming Medical University, Kunming, Yunnan Province, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"R1-20261019","first-page":"47","article-title":"When to panic over abnormal values","volume":"4","author":"Lundberg","year":"1972","journal-title":"Med Lab Obs"},{"key":"R2-20261019","doi-asserted-by":"crossref","first-page":"e70093","DOI":"10.1002\/pcn5.70093","article-title":"Frequency of abnormal results in screening laboratory tests and associated interventions in emergency psychiatric services","volume":"4","author":"Fujiwara","year":"2025","journal-title":"PCN Rep"},{"key":"R3-20261019","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13000-023-01342-8","article-title":"Critical value in surgical pathology: evaluating the current status in a multicenter study","volume":"18","author":"Soleimani","year":"2023","journal-title":"Diagn Pathol"},{"key":"R4-20261019","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.3390\/ejihpe13080110","article-title":"Metabolic adverse effects of psychotropic drug therapy: a systematic review","volume":"13","author":"Sep\u00falveda-Lizcano","year":"2023","journal-title":"Eur J Investig Health Psychol Educ"},{"key":"R5-20261019","first-page":"1162","article-title":"Chinese expert consensus on critical value management in interventional treatment of peripheral vascular diseases","volume":"34","author":"Mengyao","year":"2025","journal-title":"J Interv Radiol"},{"key":"R6-20261019","first-page":"1","article-title":"Emergency Medicine Branch, PLA Committee of Emergency Medicine. Expert consensus on the construction and standardization of emergency laboratory testing capacity","volume":"43","year":"2020","journal-title":"Chin J Lab Med"},{"key":"R7-20261019","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00213-023-06484-7","article-title":"The therapeutic reference range of venlafaxine for the treatment of depression has been revised to include a systematic review and meta-analysis","volume":"241","author":"Lense","year":"2024","journal-title":"Psychopharmacology (Berlin)"},{"key":"R8-20261019","doi-asserted-by":"crossref","first-page":"104077","DOI":"10.1016\/j.nsa.2024.104077","article-title":"Therapeutic reference range of duloxetine in the treatment of depression: a systematic review and meta-analysis","volume":"3","author":"Amann","year":"2024","journal-title":"Neurosci Appl"},{"key":"R9-20261019","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: updated 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"R10-20261019","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.3390\/pharmaceutics15092181","article-title":"Therapeutic drug monitoring (TDM) implementation in public hospitals in Greece in 2003 and 2021: a comparative analysis of TDM evolution over time","volume":"15","author":"Voulgaridou","year":"2023","journal-title":"Pharmaceutics"},{"key":"R11-20261019","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3390\/diagnostics15050604","article-title":"Visualization of critical limits and values facilitates interpretation","volume":"15","author":"Shah","year":"2025","journal-title":"Diagnostics"},{"key":"R12-20261019","first-page":"897","article-title":"Expert consensus on the application and management of point-of-care testing in critical and acute illness","volume":"36","year":"2024","journal-title":"Chin Crit Care Med"},{"key":"R13-20261019","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.clinbiochem.2014.09.021","article-title":"Retrospective evaluation of therapeutic drug monitoring of clozapine and norclozapine in Belgium using a multidrug UHPLC\u2013MS\/MS method","volume":"47","author":"Patteet","year":"2014","journal-title":"Clin Biochem"},{"key":"R14-20261019","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/s-2004-832687","article-title":"AGNP\u2013TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry","volume":"37","author":"Baumann","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"R15-20261019","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/clinchem\/hvae120","article-title":"Critical results in laboratory medicine","volume":"70","author":"Truijens","year":"2024","journal-title":"Clin Chem"},{"key":"R16-20261019","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/FTD.0000000000001264","article-title":"How can we systematically determine the therapeutic reference ranges for psychotropic drugs? Recommendations for the TDM Task Force of the AGNP","volume":"47","author":"Hart","year":"2025","journal-title":"Ther Drug Monit"},{"key":"R17-20261019","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00007691-200502000-00004","article-title":"Cost-effectiveness of Therapeutic Drug Monitoring Committee of the International Association for Therapeutic Drug Monitoring and Clinical Toxicology. Cost-effectiveness of therapeutic drug monitoring: a systematic review","volume":"27","author":"Touw","year":"2005","journal-title":"Ther Drug Monit"},{"key":"R18-20261019","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1111\/bcp.16164","article-title":"Economic evaluation of therapeutic drug monitoring interventions in acute hospital-based settings: a systematic review","volume":"90","author":"Carland","year":"2024","journal-title":"Br J Clin Pharmacol"},{"key":"R19-20261019","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/cpt.3193","article-title":"A score to predict the clinical usefulness of therapeutic drug monitoring: application to oral, molecular, targeted therapies in cancer","volume":"116","author":"G\u00e9raud","year":"2024","journal-title":"Clin Pharmacol Ther"},{"key":"R20-20261019","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/FTD.0000000000001095","article-title":"Challenges in therapeutic drug monitoring: optimizing biological treatments in patients with inflammatory bowel disease and other immune-mediated inflammatory diseases","volume":"45","author":"Papamichael","year":"2023","journal-title":"Ther Drug Monit"},{"key":"R21-20261019","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1080\/17425255.2021.1974400","article-title":"Therapeutic drug monitoring of clozapine in adults with schizophrenia: a review of challenges and strategies","volume":"17","author":"Molden","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R22-20261019","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S2215-0366(21)00251-0","article-title":"Prevalence and treatment of depressive disorders in China: a cross-sectional epidemiological study","volume":"8","author":"Lu","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"R23-20261019","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev-clinpsy-081219-105402","article-title":"DSM-5 level of personality functioning: refocusing personality disorder on what it means to be human","volume":"17","author":"Sharp","year":"2021","journal-title":"Annu Rev Clin Psychol"},{"key":"R24-20261019","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/15622975.2018.1439595","article-title":"Therapeutic TDM in psychiatry and neurology: a comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017: a tool for clinicians","volume":"19","author":"Schoretsanitis","year":"2018","journal-title":"World J Biol Psychiatry"},{"key":"R25-20261019","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1515\/cclm-2025-0186","article-title":"Standardization challenges in antipsychotic drug monitoring: insights from a national survey of Chinese TDM practices","volume":"63","author":"Zhou","year":"2025","journal-title":"Clin Chem Lab Med"},{"key":"R26-20261019","first-page":"484","article-title":"Expert consensus on standardization of reporting procedures for critical values in medical testing","volume":"39","year":"2016","journal-title":"Chin J Lab Med"},{"key":"R27-20261019","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"R28-20261019","first-page":"79","article-title":"Construction and evaluation of critical value closed-loop management practices based on knowledge-based methods","volume":"29","author":"Chaozeng","year":"2025","journal-title":"China Hosp"},{"key":"R29-20261019","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1515\/cclm-2024-0117","article-title":"Web-accessible critical limits and critical values for urgent clinician notification","volume":"62","author":"Kost","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"R30-20261019","doi-asserted-by":"crossref","first-page":"11520","DOI":"10.1038\/s41598-024-62402-7","article-title":"Identification and characterization of critical values in therapeutic drug monitoring: a retrospective analysis","volume":"14","author":"Xiao","year":"2024","journal-title":"Sci Rep"},{"key":"R31-20261019","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1192\/bjp.2021.38","article-title":"Closing the asylum: the mental patient in modern society: reflection","volume":"219","author":"Beveridge","year":"2021","journal-title":"Br J Psychiatry"},{"key":"R32-20261019","first-page":"1849","article-title":"Application of MDT combined with critical value management for prevention and control of hospital infections caused by MDROs","volume":"32","author":"Zhengmin","year":"2022","journal-title":"Chin J Nosocomial Inf"},{"key":"R33-20261019","first-page":"603","article-title":"Analysis on distribution and risk factors of electrocardiogram critical value in psychiatric patients","volume":"30","author":"Cheng","year":"2024","journal-title":"Chin J Drug Abuse Prev Treat"},{"key":"R34-20261019","doi-asserted-by":"crossref","first-page":"194","DOI":"10.5498\/wjp.v14.i2.194","article-title":"Keeping in mind sex differences when prescribing psychotropic drugs","volume":"14","author":"Mazza","year":"2024","journal-title":"World J Psychiatry"},{"key":"R35-20261019","first-page":"624","article-title":"Analysis of critical value characteristics at regional testing centers","volume":"43","author":"Chen","year":"2025","journal-title":"J Clin Lab Sci"},{"key":"R36-20261019","doi-asserted-by":"crossref","first-page":"20486","DOI":"10.1038\/s41598-025-05343-z","article-title":"Clinical characteristics and outcomes of critically-ill elderly patients aged 90 years and older","volume":"15","author":"Amado","year":"2025","journal-title":"Sci Rep"},{"key":"R37-20261019","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12877-024-05584-z","article-title":"Polypharmacy and anticholinergic burden scales in older adults: a cross-sectional study of psychiatric outpatients in a tertiary care hospital","volume":"25","author":"Bidarolli","year":"2025","journal-title":"BMC Geriatr"},{"key":"R38-20261019","first-page":"1044","article-title":"Retrospective analysis and evaluation of critical values in emergency laboratories","volume":"18","author":"Yang","year":"2023","journal-title":"China Med J"},{"key":"R39-20261019","first-page":"1038","article-title":"A retrospective analysis and discussion of emergency critical value reporting in laboratory departments","volume":"11","year":"2024","journal-title":"The Chin J Disaster Rescue Med"},{"key":"R40-20261019","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S2215-0366(24)00097-X","article-title":"Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case-control study in Finland","volume":"11","author":"Rubio","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"R41-20261019","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00702-023-02589-7","article-title":"Antipsychotic drug-induced neutropenia: results from the AMSP Drug Surveillance Program between 1993 and 2016","volume":"130","author":"Glocker","year":"2023","journal-title":"J Neural Transm"},{"key":"R42-20261019","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/JCP.0000000000001683","article-title":"New-onset agocytosis during long-term treatment with olanzapine","volume":"43","author":"Lee","year":"2023","journal-title":"J Clin Psychopharmacol"},{"key":"R43-20261019","first-page":"2806","article-title":"Exploring hypokalemia in patients with mental disorders treated with antipsychotic drugs","volume":"33","author":"Wu","year":"2012","journal-title":"Jilin Med J"},{"key":"R44-20261019","doi-asserted-by":"crossref","first-page":"6584","DOI":"10.3390\/jcm14186584","article-title":"Drug-induced hyponatremia: insights into pharmacological mechanisms and clinical practice management","volume":"14","author":"Capinha","year":"2025","journal-title":"J Clin Med"},{"key":"R45-20261019","first-page":"820","article-title":"Principal component regression analysis of critical value data in neonatal department laboratory tests of a tertiary hospital","volume":"33","author":"Jun","year":"2016","journal-title":"Chin J Health Stats"},{"key":"R46-20261019","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.amjmed.2021.04.007","article-title":"Risk of electrolyte disorders, syncope, and falls in patients taking thiazide diuretics: results of a cross-sectional study","volume":"134","author":"Ravioli","year":"2021","journal-title":"Am J Med"},{"key":"R47-20261019","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41380-022-01770-w","article-title":"Impact of pharmacological and non-pharmacological interventions on physical health outcomes in people with mood disorders across their lifespan: an umbrella review of evidence from randomized controlled trials","volume":"28","author":"Croatto","year":"2023","journal-title":"Mol Psychiatry"},{"key":"R48-20261019","first-page":"65","article-title":"Research progress on the impact of antipsychotic drugs on QTc interval","volume":"52","author":"Hao","year":"2024","journal-title":"J Guangzhou Med Univ"},{"key":"R49-20261019","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12991-023-00465-y","article-title":"Role of trazodone in treatment of major depressive disorder: an update","volume":"22","author":"Fagiolini","year":"2023","journal-title":"Ann Gen Psychiatry"},{"key":"R50-20261019","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41397-022-00281-9","article-title":"Pharmacogenomics of clozapine-induced agranulocytosis: a systematic review and meta-analysis","volume":"22","author":"Islam","year":"2022","journal-title":"Pharmacogenomics J"},{"key":"R51-20261019","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1192\/bjp.2023.27","article-title":"Optimizing plasma clozapine levels to improve treatment response: individual patient data meta-analysis and receiver operating characteristic curve analysis","volume":"222","author":"Northwood","year":"2023","journal-title":"Br J Psychiatry"},{"key":"R52-20261019","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s40265-021-01556-4","article-title":"Antipsychotic polypharmacy for the management of schizophrenia: evidence and recommendations","volume":"81","author":"L\u00e4hteenvuo","year":"2021","journal-title":"Drugs"},{"key":"R53-20261019","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/pcn.13785","article-title":"Second-generation antipsychotic-induced dystonia: analysis using the Japanese Adverse Drug Event Report (JADER) database","volume":"79","author":"Ebina","year":"2025","journal-title":"Psychiatry Clin Neurosci"},{"key":"R54-20261019","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.30773\/pi.2025.0174","article-title":"Analysis of antipsychotic drug use patterns and safety in patients with bipolar disorder","volume":"22","author":"Cheng","year":"2025","journal-title":"Psychiatry Investig"},{"key":"R55-20261019","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.3390\/jcm12123897","article-title":"Delirium in medically-hospitalized patients: prevalence, recognition, and risk factors: a prospective cohort study","volume":"12","author":"Al Farsi","year":"2023","journal-title":"J Clin Med"},{"key":"R56-20261019","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.3390\/jcm14176186","article-title":"Association of aspiration pneumonia-related factors with the incidence of healthcare-associated pneumonia in elderly with dementia","volume":"14","author":"Miyamoto","year":"2025","journal-title":"J Clin Med"},{"key":"R57-20261019","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.3390\/jcm13102776","article-title":"Biochemical, hematological, inflammatory, and gut permeability biomarkers in patients with alcohol withdrawal syndrome with and without delirium tremens","volume":"13","author":"Melamud","year":"2024","journal-title":"J Clin Med"},{"key":"R58-20261019","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.3390\/jcm14196951","article-title":"Insomnia and benzodiazepine use as risk factors for erectile dysfunction: clinical evidence and in silico analysis of physicochemical properties","volume":"14","author":"Navarrete-Anaya","year":"2025","journal-title":"J Clin Med"},{"key":"R59-20261019","first-page":"285","article-title":"Case 226: a 41-year-old female with a 7-year history of elevated blood pressure","volume":"29","author":"Lian","year":"2021","journal-title":"Chin J Hypertens"},{"key":"R60-20261019","doi-asserted-by":"crossref","first-page":"530","DOI":"10.37765\/ajmc.2022.89250","article-title":"Impact of HDHPs on service use and spending for substance-use disorders","volume":"28","author":"Eisenberg","year":"2022","journal-title":"Am J Manag Care"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001529","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:05:01Z","timestamp":1792415101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":60,"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001529","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,19]]},"assertion":[{"value":"2026-06-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}